Glossary -- The clinical disease -- Treatment objectives -- Uncomplicated malaria -- Severe malaria --

Diagnosis of malaria -- Clinical diagnosis -- Parasitological diagnosis -- Where malaria transmission is

low-moderate and/or unstable -- In stable high-transmissión settings -- Malaria parsie species identification

-- In epidemics and complex emergencies -- Resistance to antimalarial medicines -- impact of resistance --

Global disribution of resistance -- Assessing resistance -- Antimalarial tratment policy -- Assessment of in

vivo therapeutic efficacy -- Criteria for antimalarial treatment policy change -- Treatment of uncomplicated

P. Falciparum malaria -- Assessment -- Antimalarial combination therapy -- The choice of artemisinin based

combination therapy options -- Practical aspects of treatment with recommended ACTs -- incorrect approaches to

treatment -- Additional aspects of clinical management -- Operational issues in treatment management --

Management of treatment failures -- Treatment in specific populations and situations -- Coexisting morbidities

-- Treatment of severe falciparum malaria -- Treatment of malaria caused by P. vivax, P. ovale, or P. malariae

-- Mixed Malaria infections -- complex emergencies and epidemics -- Annexes -- The guidelines Development

process -- Adaptation of WHO malaria treatment guidelines for use in countries -- Pharmacology of antimalarial

drugs -- Antimalarials and malaria transmissión -- Malaria diagnosis -- Resistance to antimalarials --

Uncomplicated P. faciparum malaria -- Malaria treatment and HIV/AIDS -- Treatment of severe P. faciparum

malaria -- Treatment of P. vivax, P. ovale and P. malariae infections --